Showing results (151-160 of 1,579) with videos related to

Sort By:
Pageof 158
RSC Medicinal Chemistry|February 9, 2023
Correction: Thiamine analogues as inhibitors of pyruvate dehydrogenase and discovery of a thiamine analogue with non-thiamine related antiplasmodial activityAlex H Y Chan, Imam Fathoni, Terence C S Ho, et al.
RSC Medicinal Chemistry|November 17, 2025
Glioblastoma antitumoral activity of tetrahydroquinoline-derived triarylmethanesDaniela S N Branco, Zahra Hosseinpur Yektaei, Sureka Chandrabose, et al.
RSC Medicinal Chemistry|November 24, 2025
Schweinfurthins and their analogues are highly selective cellular probes for oxysterol-binding protein (OSBP)Laura Depta, Nianzhe He, Maria Lillevang Madsen, et al.
RSC Medicinal Chemistry|November 20, 2025
Design and evaluation of an HSP70-targeting PROTAC in synergy with an HSF1 inhibitor for enhanced antitumor activityWei-Hao Huang, Teng-Yu Mao, Guo-Yao Dai, et al.
RSC Medicinal Chemistry|November 17, 2025
Recent advances in the antimicrobial potential of boron cluster compoundsWilliam J Price Cunliffe, Peter J Rutledge, Louis M Rendina
RSC Medicinal Chemistry|November 10, 2025
Design and synthesis of isoxazole-functionalized benzene sulphonamides as novel inhibitors of Mycobacterium tuberculosis β-carbonic anhydrasesRani Bandela, Anuradha Singampalli, Sarvan Maddipatla, et al.
RSC Medicinal Chemistry|November 10, 2025
Novel chalcone 2-thiopyrimidine conjugates as dual VEGFR-2/BRAF inhibitors: design, synthesis, in vitro cytotoxicity, and molecular docking studyRanda Atef Ibrahim Abdelaziz, Heba Abdelrasheed Allam, Ahmed Mahmoud El Kerdawy, et al.
RSC Medicinal Chemistry|November 21, 2025
An exploration of potent antileishmanial agents derived from quinoline-thiazole and thiadiazole hybrids, targeting DHFR-TS and PTR1: design, synthesis, and computational analysesHuda R M Rashdan, Adnan A Bekhit, Veronika Furlan, et al.
RSC Medicinal Chemistry|November 14, 2025
Novel magnolol-sulforaphane hybrids as potent antitumor agents: synthesis and biological characterizationYuwei Peng, Bing Liu, Yishan Guo, et al.
RSC Medicinal Chemistry|January 23, 2026
Recent progress of METTL3 inhibitors for cancer therapeutics: design, optimization and potential applicationsYun Zhang, Mengxiang Quan, Qinlan Chen, et al.
Pageof 158